Evidence map›Paper›PMID 27648439›Full record

SynthesisCanadian journal of gastroenterology & hepatology2016

Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review.

Harsha Moole, Sirish Dharmapuri, Abhiram Duvvuri, Sowmya Dharmapuri, Raghuveer Boddireddy, Vishnu Moole, Prathyusha Yedama, Naveen Bondalapati, Achuta Uppu, Charan Yerasi

Open access · goldAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Canadian journal of gastroenterology & hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Practice guidelines for managing extrahepatic biliary tract cancers.Annals of hepato-biliary-pancreatic surgery · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Harsha MooleDivision of General Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA.ORCID 0000-0002-7516-5980
Sirish DharmapuriDepartment of Internal Medicine, Wilkes-Barre Veterans Affairs Medical Center, Scranton, PA, USA.
Abhiram DuvvuriDepartment of Gastroenterology and Hepatology, Kansas City Veteran Affairs Medical Center, Kansas City, MO, USA.
Sowmya DharmapuriDivision of General Internal Medicine, NTR University of Health Sciences, Andhra Pradesh, India.
Raghuveer BoddireddyDivision of General Internal Medicine, NTR University of Health Sciences, Andhra Pradesh, India.
Vishnu MooleDivision of General Internal Medicine, NTR University of Health Sciences, Andhra Pradesh, India.
Prathyusha YedamaDivision of General Internal Medicine, NTR University of Health Sciences, Andhra Pradesh, India.
Naveen BondalapatiDivision of Medicine, Barnes Jewish Christian Medical Group, Christian Hospital, St. Louis, MO, USA.
Achuta UppuDepartment of Medicine, Bronx Lebanon Hospital Center, Bronx, NY, USA; Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Charan YerasiDepartment of Medicine, MedStar Georgetown University Hospital and MedStar Washington Hospital Center, Washington, DC, USA.ORCID 0000-0002-3916-3216
Dr. NTR University of Health Sciences · INWilkes-Barre VA Medical Center · USBronx-Lebanon Hospital Center · USKansas City VA Medical Center · USMedStar Washington Hospital Center · USUniversity of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Palliation in advanced unresectable hilar malignancies can be achieved by endoscopic (EBD) or percutaneous transhepatic biliary drainage (PTBD). It is unclear if one approach is superior to the other in this group of patients. Aims. Compare clinical outcomes of EBD versus PTBD. Methods. (i) Study Selection Criterion. Studies using PTBD and EBD for palliation of advanced unresectable hilar malignancies. (ii) Data Collection and Extraction. Articles were searched in Medline, PubMed, and Ovid journals. (iii) Statistical Method. Fixed and random effects models were used to calculate the pooled proportions. Results. Initial search identified 786 reference articles, in which 62 articles were selected and reviewed. Data was extracted from nine studies (N = 546) that met the inclusion criterion. The pooled odds ratio for successful biliary drainage in PTBD versus EBD was 2.53 (95% CI = 1.57 to 4.08). Odds ratio for overall adverse effects in PTBD versus EBD groups was 0.81 (95% CI = 0.52 to 1.26). Odds ratio for 30-day mortality rate in PTBD group versus EBD group was 0.84 (95% CI = 0.37 to 1.91). Conclusions. In patients with advanced unresectable hilar malignancies, palliation with PTBD seems to be superior to EBD. PTBD is comparable to EBD in regard to overall adverse effects and 30-day mortality.

Indexed as

AdultBile Duct NeoplasmsCholestasisDrainageEndoscopyFemaleHumansKlatskin TumorMaleMiddle AgedOdds RatioPalliative Care

Identifiers

PMID27648439
PMCPMC5014937
OpenAlexW2509596120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.